MNPR - Latest News
Monopar Therapeutics Inc. (MNPR), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $728.1M. Beta to the broader market is 1.48.
The article list below shows the most recent MNPR headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent MNPR Headlines
Monopar Therapeutics: ALXN1840's Bull Case Has Improved
seekingalpha.com - Jul 3, 2026
Monopar Therapeutics has evolved from early radiopharma assets into a more concrete bet with ALXN1840 for rare diseases. ALXN1840 is their Wilson dis
Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease
globenewswire.com - Jun 30, 2026
WILMETTE, Ill. , June 30, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc.
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
globenewswire.com - Jun 26, 2026
WILMETTE, Ill. , June 26, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc.
Wall Street Analysts Believe Monopar Therapeutics (MNPR) Could Rally 88.92%: Here's is How to Trade
zacks.com - Jun 15, 2026
The mean of analysts' price targets for Monopar Therapeutics (MNPR) points to an 88. 9% upside in the stock.
Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026
globenewswire.com - Jun 1, 2026
WILMETTE, Ill. , June 01, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc.
How News Affects MNPR Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MNPR's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked MNPR news questions
- What is the latest MNPR news headline?
- The most recent MNPR headline (Jul 3, 2026) is "Monopar Therapeutics: ALXN1840's Bull Case Has Improved". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the MNPR news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What MNPR news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual MNPR options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.